Neuronbc Join Pharmaconex Egypt 2026 with Local Distributor at Booth H4J10

Cairo, Egypt – September 1~3, 2026-Neuronbc joined Pharmaconex 2026 in Cairo together with its authorized Egyptian distributor. Our booth featured Integtest V8.0 filter integrity tester and CCIT solutions compliant with USP <1207> & 21 CFR Part 11.

During the three‑day event, Neuronbc displayed its flagship filter integrity test system Integtest V8.0,V10, alongside CCIT container closure integrity testers, Total organic carbon analyzer, Glove Integrity Tester and related pharma laboratory solutions. These instruments comply with USP <1207>, FDA 21 CFR Part 11 and major GMP requirements, addressing critical quality control demands for local pharmaceutical manufacturers across Egypt and surrounding MENA markets.

"We see strong market potential within Egypt and neighboring countries. Local manufacturers are upgrading quality control systems to meet international compendia standards," commented the Neuronbc overseas sales representative on site. "Working closely with our Egyptian partner, we aim to provide cost‑effective, regulatory‑compliant testing solutions and solid local service for regional pharmaceutical factories."

Moving forward, Neuronbc will keep expanding its MENA market presence via regional exhibitions and local distributor cooperation, empowering pharmaceutical quality control across the Middle East and North Africa.